BiogenBiogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates2 days agoMore
BioPharma DiveBiogen to buy startup Alcyone, eyeing easier delivery of RNA drugs2 days agoBy Kristin JensenMore
TipRanksM&A News: Biotech Biogen Buys Alcyone Therapeutics for $85M to Boost Brain Treatments2 days agoBy David CraikMore
The Business JournalsBiogen acquires Lowell firm developing device meant replace the spinal tap2 days agoBy Don SeiffertMore
TipRanksBiogen’s Strategic Acquisition of Alcyone Therapeutics: A Cautious Hold Amid Promising Potential2 days agoMore
insights.citeline.comDeal Watch: Biogen Acquires Intrathecal Delivery Specialist Alcyone11 hours agoBy Joseph HaasMore
BenzingaBiogen's $85 Million Deal Could Change How Patients Get Spinraza Treatment2 days agoBy Vandana SinghMore
geneonline.comBiogen to Acquire Alcyone Therapeutics in $85 Million Deal Focused on ThecaFlex DRx Device for Neurological Treatments20 hours agoMore
FirstWord PharmaBiogen snaps up Alcyone and its intrathecal delivery platform for $85M upfront16 hours agoBy Pavan KamatMore
MarketScreenerBiogen Inc. entered into a definitive agreement to acquire All Assets of Alcyone Therapeutics, Inc. for $85 million.2 days agoMore